Today I want to talk about what actually happens in your body over time when you’re on a GLP-1 peptide for weight loss. Because the reality is, nothing about these peptides works like a switch you flip on. You don’t wake up one day and suddenly “stop being hungry.” What actually happens is slower, more […]
glp1
The Truth About Weight Loss
Today, we’re diving into a question almost everyone asks when they start thinking about weight loss: “What’s the best diet for losing weight?” And I’m going to tell you something straight away there isn’t one. There’s no magic plan, no secret pill or injection, no ratio of carbs to fat that guarantees fat loss for […]
Why GLP-1 Weight Loss Can Slow
Today, we’re talking about something that can be both confusing and frustrating — why weight loss can slow down on GLP-1 medications, and how other diabetes medications, like metformin or sulfonylureas, can play a role. Let’s start with the weight loss medications themselves. Semaglutide is a GLP-1 receptor agonist. It mimics the body’s natural GLP-1 […]
Fatigue on Semaglutide or Tirzepatide
If you’ve started a GLP-1 medication and found yourself thinking, “Why am I so tired all of a sudden?”, you’re definitely not alone. Today, we’re talking specifically about fatigue with semaglutide and tirzepatide—what the research actually shows, why fatigue seems more common with some GLP-1s than others, and what you can do if your energy […]
Nutrient Tips While on GLP‑1 Medications
Today we’re going to talk about something that’s becoming really important for anyone taking medications like Ozempic, Wegovy, or other GLP‑1 receptor agonists. You probably already know the benefits of GLP-1s—smaller appetite, better blood sugar control, and noticeable weight loss. But here’s the catch: eating less can sometimes mean you’re also taking in fewer essential […]
Finding the Right Fit: Semaglutide, Tirzepatide, or Retatrutide
Today, we’re tackling a question that comes up often in peptide, weight loss, and nutrition clinics: why does one person see great results with semaglutide, while another responds better to tirzepatide—or even retatrutide? All three peptides target the incretin system, but they act in slightly different ways—and those differences can dramatically affect outcomes. Let’s start […]